Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 25% ± 6% | |
fibroblast | 8 studies | 19% ± 4% | |
natural killer cell | 7 studies | 20% ± 5% | |
endothelial cell of lymphatic vessel | 7 studies | 23% ± 3% | |
epithelial cell | 7 studies | 37% ± 15% | |
basal cell | 7 studies | 27% ± 10% | |
ciliated cell | 6 studies | 24% ± 9% | |
pericyte | 6 studies | 19% ± 2% | |
B cell | 5 studies | 22% ± 5% | |
hematopoietic precursor cell | 4 studies | 30% ± 15% | |
abnormal cell | 4 studies | 29% ± 9% | |
macrophage | 4 studies | 21% ± 5% | |
goblet cell | 4 studies | 24% ± 4% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 25% ± 6% | |
CD8-positive, alpha-beta T cell | 3 studies | 22% ± 5% | |
classical monocyte | 3 studies | 33% ± 13% | |
plasmablast | 3 studies | 37% ± 10% | |
myeloid cell | 3 studies | 24% ± 5% | |
smooth muscle cell | 3 studies | 19% ± 4% | |
astrocyte | 3 studies | 24% ± 2% | |
dendritic cell | 3 studies | 37% ± 22% | |
enteroendocrine cell | 3 studies | 19% ± 4% | |
intestinal crypt stem cell | 3 studies | 22% ± 6% | |
myofibroblast cell | 3 studies | 23% ± 4% | |
transit amplifying cell | 3 studies | 35% ± 12% | |
oligodendrocyte | 3 studies | 19% ± 3% | |
erythroblast | 3 studies | 40% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11466.80 | 1445 / 1445 | 100% | 92.63 | 183 / 183 |
liver | 100% | 6254.35 | 226 / 226 | 100% | 63.73 | 406 / 406 |
pancreas | 100% | 7741.77 | 328 / 328 | 100% | 75.19 | 178 / 178 |
prostate | 100% | 10114.02 | 245 / 245 | 100% | 98.31 | 502 / 502 |
skin | 100% | 14027.73 | 1809 / 1809 | 100% | 139.85 | 472 / 472 |
stomach | 100% | 7921.03 | 359 / 359 | 100% | 99.21 | 286 / 286 |
uterus | 100% | 8895.45 | 170 / 170 | 100% | 103.52 | 458 / 459 |
lung | 100% | 7448.92 | 577 / 578 | 100% | 98.79 | 1154 / 1155 |
breast | 100% | 9498.20 | 459 / 459 | 100% | 93.90 | 1115 / 1118 |
kidney | 100% | 6275.18 | 89 / 89 | 100% | 63.71 | 897 / 901 |
intestine | 100% | 10574.90 | 966 / 966 | 99% | 114.76 | 524 / 527 |
thymus | 100% | 6941.71 | 652 / 653 | 100% | 61.77 | 602 / 605 |
ovary | 100% | 8429.12 | 180 / 180 | 99% | 59.18 | 427 / 430 |
bladder | 100% | 11782.10 | 21 / 21 | 99% | 107.18 | 499 / 504 |
brain | 99% | 4384.53 | 2605 / 2642 | 100% | 74.45 | 705 / 705 |
adrenal gland | 100% | 8767.67 | 258 / 258 | 97% | 65.50 | 224 / 230 |
adipose | 100% | 9389.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 119.53 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 147.34 | 29 / 29 |
muscle | 100% | 13202.76 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10115.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.98 | 1 / 1 |
blood vessel | 100% | 7967.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 5599.35 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 86% | 5751.48 | 801 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0075522 | Biological process | IRES-dependent viral translational initiation |
GO_0075525 | Biological process | viral translational termination-reinitiation |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0006413 | Biological process | translational initiation |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0071541 | Cellular component | eukaryotic translation initiation factor 3 complex, eIF3m |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0031369 | Molecular function | translation initiation factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF3B |
Protein name | Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) Eukaryotic translation initiation factor 3 subunit B Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116) eIF3B protein |
Synonyms | EIF3S9 hCG_1998988 tcag7.544 |
Description | FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis . The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation . The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression . .; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 . . FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is involved in protein synthesis and, together with other initiation factors, stimulates binding of mRNA and methionyl-tRNAi to the 40S ribosome. .; FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is involved in protein synthesis and, together with other initiation factors, stimulates binding of mRNA and methionyl-tRNAi to the 40S ribosome. .; FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is involved in protein synthesis and, together with other initiation factors, stimulates binding of mRNA and methionyl-tRNAi to the 40S ribosome. .; FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. . |
Accessions | A4D210 P55884 B4DV79 ENST00000360876.9 [P55884-1] Q96G38 C9JQN7 ENST00000431643.5 ENST00000397011.2 [P55884-1] C9JZG1 ENST00000413917.5 B4DXN6 |